Tracking blood markers of immune recovery over time
This study follows healthy people over time and measures tiny markers in blood that reflect how your immune system is maintained. It may help researchers understand normal immune aging, which can also guide care for people with immune problems later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy for your age (no recent serious infections, injuries, or immune problems)
- You do not have severe long-term illnesses
- You have no history of cancer (except a one-time non-melanoma skin cancer)
- You do not have serious heart disease or problems controlling blood pressure
- You do not have chronic infections or long-term uncontrolled inflammatory arthritis
- You do not have severe diabetes or any other severe condition that affects daily functioning or needs multiple medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study takes small blood samples to learn how the immune system works in healthy people. It may help researchers better understand immune biology for future treatments, while you help by participating in regular research blood draws.
This study looks at how certain fats in your blood interact with immune cells. It is for healthy people to help researchers understand normal immune function, which may lead to better treatments for inflammatory diseases.
This study checks whether certain lab “biomarker” results from blood samples remain accurate over time. The goal is to validate diagnostic tests by testing samples from healthy adults under controlled conditions.
This study measures how a child’s immune system responds after standard childhood vaccines, like DTaP-IPV/Hib, pneumococcal, MMR, varicella, flu, and COVID shots. It may help researchers better understand what a “healthy” immune response looks like after vaccination.
This study looks at how certain immune cells (natural killer T cells) behave in people with systemic lupus, by measuring specific immune receptor markers in blood. It may help researchers better understand lupus and how it can connect with other conditions like antiphospholipid syndrome or Sjögren’s.
Hear when a new Telomere Length in Healthy Controls trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.